ETHOSUXIMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ethosuximide, and what generic alternatives are available?
Ethosuximide is a drug marketed by Bionpharma, Epic Pharma Llc, Heritage Pharms Inc, Puracap Pharm Llc, Strides Pharma, Mikart, Pharm Assoc, and Teva Pharms. and is included in eight NDAs.
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethosuximide
A generic version of ETHOSUXIMIDE was approved as ethosuximide by PHARM ASSOC on November 22nd, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETHOSUXIMIDE?
- What are the global sales for ETHOSUXIMIDE?
- What is Average Wholesale Price for ETHOSUXIMIDE?
Summary for ETHOSUXIMIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 12 |
| Patent Applications: | 3,982 |
| Drug Prices: | Drug price information for ETHOSUXIMIDE |
| What excipients (inactive ingredients) are in ETHOSUXIMIDE? | ETHOSUXIMIDE excipients list |
| DailyMed Link: | ETHOSUXIMIDE at DailyMed |
Recent Clinical Trials for ETHOSUXIMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 3 |
| Tanta University | Phase 3 |
| Zhejiang University | Early Phase 1 |
Pharmacology for ETHOSUXIMIDE
| Drug Class | Anti-epileptic Agent |
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for ETHOSUXIMIDE
Anatomical Therapeutic Chemical (ATC) Classes for ETHOSUXIMIDE
US Patents and Regulatory Information for ETHOSUXIMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 040430-001 | Oct 28, 2002 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pharm Assoc | ETHOSUXIMIDE | ethosuximide | SYRUP;ORAL | 040253-001 | Nov 22, 2000 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Puracap Pharm Llc | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 210654-001 | Mar 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | ETHOSUXIMIDE | ethosuximide | SYRUP;ORAL | 081306-001 | Jul 30, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 040686-001 | May 28, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Heritage Pharms Inc | ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 200892-001 | Sep 25, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mikart | ETHOSUXIMIDE | ethosuximide | SYRUP;ORAL | 040506-001 | Dec 22, 2003 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
